|
The savvywire was discarded and not returned to the manufacturer.No inspection was possible.No imaging and no additional data were provided by the account as of april 4th, 2025.Check of the device history records (dhr) of guidewire lot number osw-0323 showed that it was released per specifications.Based on the available information, pacing test was performed before valve deployment, as prescribed, confirming ventricular capture and thresholds.Without inspecting the wire, opsens is not able to fully investigate therefore no definitive root cause can be concluded in this report.If there is any further relevant information, a follow up report will be submitted to the fda.The adverse event result of this incident is well mentioned in the savvywire instructions of use (ifu): adverse events that may result from the use of this device include, but are not limited to: access site or vessels complications, additional surgical procedure, allergic reactions, amputation, aneurysm, angina, arrhythmia, bleeding, cardiac or vessel perforation/dissection, coronary obstruction, death, embolism, fibrillation, foreign body/wire fracture, heart block, hematoma, hypotension/hypertension, infection, kidney injury/failure, myocardial infarction, need for permanent pacemaker, pericardial effusion, pneumothorax, stroke or other neurologic event, spasm, tamponade, thrombus, valve dysfunction or complications, valve malpositioning or embolization, vasospasm, vessel occlusion, wire entrapment/entanglement, x-ray radiation exposure complications.
|